NextGen Healthcare, Inc.
NXGN · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,592 | $1,077 | $1,150 | $1,250 |
| - Cash | $54 | $70 | $99 | $242 |
| + Debt | $274 | $274 | $275 | $276 |
| Enterprise Value | $1,811 | $1,281 | $1,326 | $1,284 |
| Revenue | $176 | $178 | $179 | $162 |
| % Growth | -1% | -0.2% | 10.3% | – |
| Gross Profit | $82 | $80 | $85 | $77 |
| % Margin | 46.3% | 44.8% | 47.3% | 47.3% |
| EBITDA | $19 | $22 | -$8 | $20 |
| % Margin | 11% | 12.1% | -4.3% | 12.5% |
| Net Income | $5 | $6 | -$25 | $8 |
| % Margin | 2.9% | 3.5% | -14.1% | 4.8% |
| EPS Diluted | 0.07 | 0.09 | -0.38 | 0.12 |
| % Growth | -22.2% | 123.7% | -416.7% | – |
| Operating Cash Flow | -$9 | -$8 | $8 | $2 |
| Capital Expenditures | -$10 | -$9 | -$8 | -$9 |
| Free Cash Flow | -$19 | -$17 | -$1 | -$7 |